Transactions


DISCLAIMER: Transaction value is approximate and is based on information disclosed by the parties to the transaction or other public sources. In addition, in the case of transactions consummated in currencies other than U.S. dollars, Lazard has converted the value using the exchange rate published on the date of announcement. Lazard makes no representation or warranty with respect to the accuracy or completeness of the value provided

Clear all Clear

Download results

Showing 61 to 70 of 5696 Results

June 30, 2025
France, United Kingdom

MaaT Pharma announces exclusive commercialization partnership with Clinigen for XERVYTEG in Europe

Undisclosed

June 30, 2025
France

IN Groupe and IDEMIA Group enter into exclusive negotiations for the acquisition of IDEMIA Smart Identity

Undisclosed

June 27, 2025
United States

Lazard served as the sole financial advisor to the Special Committee of the Board of Directors of MSG Sports, parent to the New York Knicks and New York Rangers, on the amendment of the teams’ respective media rights agreements with MSG Networks

Undisclosed

June 27, 2025
United States

Saks Global Announces Early Settlement of the Exchange Offer and Consent Solicitation, Completing Previously Announced $600 Million Financing Package

$2.7 Billion

June 26, 2025
United Kingdom

Network Rail enters into a ground-breaking partnership with Neos Networks and Freshwave to upgrade telecoms infrastructure

Undisclosed

June 26, 2025
France, United Kingdom

KPMG in France in exclusive negotiations with TowerBrook Capital Partners for the acquisition of its SMEs business

Undisclosed

June 25, 2025
United States

Community Bank to Acquire Seven Branches in Allentown, PA Area from Santander Bank

Undisclosed

June 25, 2025
United Arab Emirates, France

ADQ in exclusive talks to acquire 35% stake in Limagrain Vegetable Seeds

Undisclosed

June 25, 2025
United Kingdom

Lazard advises Steerco of RCF Lenders on Lowell’s Recapitalisation Transaction

$3.4 Billion

June 25, 2025
Sweden, United States

Public offer to the shareholders of Biotage is announced by KKR

$1.2 Billion